SAN DIEGO, March 11, 2025 – Resmed (NYSE: RMD, ASX: RMD), a leading health technology company focused on sleep, breathing, and in-home care, has announced a comprehensive brand evolution. This initiative aims to unify its brand portfolio, broadening its reach to serve more people and healthcare providers globally, and reflecting its growing direct-to-consumer engagement.
For 35 years, Resmed has been at the forefront of respiratory therapy innovation, including CPAP therapy and digital health solutions. The company’s last major brand update in 2014 marked its shift towards connectivity, introducing cloud-connected medical devices that revolutionized sleep apnea treatment. Today, Resmed is taking the next step, transforming into a fully unified health technology brand serving millions of consumers, healthcare professionals, and software users worldwide.
An estimated 2.3+ billion people worldwide suffer from sleep apnea, insomnia, COPD, or other respiratory insufficiencies. Furthermore, Resmed’s 2025 Global Sleep Survey highlights the widespread impact of poor sleep; one-third of respondents reported sleep difficulties, including trouble falling asleep (34%) and staying asleep (29%).
Through this brand evolution, Resmed aims to accelerate its ability to connect with people and help them sleep and breathe better to improve their overall health and well-being.
“We are at a pivotal moment in health – sleep and breathing health are gaining the attention once reserved for diet and exercise, with consumers taking a more proactive role in their care,” said Katrin Pucknat, Resmed’s Chief Marketing Officer. “Our brand evolution is more than a new look – it’s a bold step forward in our strategy to make sleep and breathing health a mainstream priority in global healthcare.”
As part of the brand evolution, Resmed plans to consolidate its brands, products, and services under a single Resmed brand over the next couple of years. This consolidation will create a more streamlined experience for both consumers and healthcare providers. The transformation includes a new visual identity, a redesigned logo, and a refreshed brand voice. These elements reinforce Resmed’s position as an approachable, people-centered, and forward-thinking health technology company.
The brand evolution aligns with Resmed’s mission to create life-changing health technologies that people love. It coincides with three major market-facing initiatives that aim to reshape perceptions of sleep therapy and increase awareness of sleep apnea treatment:
- The first U.S. based consumer campaign to destigmatize CPAP therapy and position sleep health as more accessible.
- A targeted primary care physician (PCP) education campaign in the U.S. to drive earlier diagnoses and interventions for sleep apnea.
- A sleep health awareness campaign in key markets in Asia Pacific and Europe, addressing barriers to seeking treatment for sleep apnea.
“Resmed has moved beyond its origins as a CPAP device and mask manufacturer. Our new brand reflects who we are today—a global leader in health technology that delivers solutions to help people achieve their full potential through better sleep and breathing with care delivered in the home,” said Mick Farrell, Resmed’s Chairman & CEO. “With this evolution, we are reaffirming our commitment to empowering 500 million people worldwide to achieve their full health potential by 2030 and changing the delivery of healthcare.”
To learn more about Resmed’s brand evolution, visit resmed.com/brand-evolution.
About Resmed
Resmed (NYSE: RMD, ASX: RMD) creates life-changing health technologies that people love. Committed to pioneering innovative technology, Resmed empowers millions in 140 countries to live happier, healthier lives. Their AI-powered digital health solutions, cloud-connected devices, and intelligent software make home healthcare more personalized, accessible, and effective. Resmed envisions a world where everyone achieves their full potential through better sleep and breathing, with care delivered in their home. Learn more about how they are redefining sleep health at Resmed.com and follow @Resmed.
1 Benjafield et al Lancet Respir Med 2019 2 Benjafield et al Sleep Med (suppl) 2024 3 Boers et al JAMA Network Open 2023 4 Based on over 30,000 respondents across 13 markets surveyed as part of the ResMed 2025 Global Sleep Survey between December 12-28, 2024)
